Cargando…
Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue
BACKGROUND: Oxaliplatin and related chemotherapeutic drugs cause painful chronic peripheral neuropathies in cancer patients. We investigated changes in neuronal size profiles and neurofilament immunoreactivity in L5 dorsal root ganglion (DRG) tissue of adult female Wistar rats after multiple-dose tr...
Autores principales: | Jamieson, Stephen MF, Subramaniam, Joshuan, Liu, Johnson J, Jong, Nancy N, Ip, Virginia, Connor, Bronwen, McKeage, Mark J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785764/ https://www.ncbi.nlm.nih.gov/pubmed/19922644 http://dx.doi.org/10.1186/1744-8069-5-66 |
Ejemplares similares
-
Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity
por: Jamieson, S M F, et al.
Publicado: (2003) -
Neurofilament-dependent Radial Growth of Motor Axons and Axonal Organization of Neurofilaments Does Not Require the Neurofilament Heavy Subunit (NF-H) or Its Phosphorylation
por: Rao, Mala V., et al.
Publicado: (1998) -
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
por: Han, Catherine H., et al.
Publicado: (2017) -
Requirement of Heavy Neurofilament Subunit in the Development of Axons with Large Calibers
por: Elder, Gregory A., et al.
Publicado: (1998) -
Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles
por: Myint, Khine, et al.
Publicado: (2015)